Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cappellini

Showing results (781-790 of 863) with videos related to

Pageof 87
Sort By:
Haematologica|December 3, 2009
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemiasMaria Domenica Cappellini, John Porter, Amal El-Beshlawy, et al.
Journal of Translational Medicine|May 3, 2015
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanomaCarmela Rozera, Giancarlo Antonini Cappellini, Giuseppina D'Agostino, et al.
Melanoma Research|January 3, 2020
Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)Victoria Atkinson, Shahneen Sandhu, Geke Hospers, et al.
Annual Review of Biochemistry|May 1, 2018
Ancient Biomolecules and Evolutionary InferenceEnrico Cappellini, Ana Prohaska, Fernando Racimo, et al.
Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.
Haematologica|May 23, 2020
2'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring HbA production and chain rebalanceAlisa Dong, Valentina Ghiaccio, Irene Motta, et al.
European Journal of Haematology|April 24, 2023
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspaterceptMaria Domenica Cappellini, Ali T Taher, Antonio Piga, et al.
European Journal of Gastroenterology & Hepatology|June 5, 2025
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient settingDavide Scalvini, Cristina Bezzio, Stiliano Maimaris, et al.
Cancer Investigation|February 4, 2014
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access programPaolo Antonio Ascierto, Ester Simeone, Vanna Chiarion Sileni, et al.
Orphanet Journal of Rare Diseases|June 1, 2019
Current challenges in the management of patients with sickle cell disease - A report of the Italian experienceGiovanna Russo, Lucia De Franceschi, Raffaella Colombatti, et al.
Pageof 87

Showing results (781-790 of 863) with videos related to

Sort By:
Pageof 87
Haematologica|December 3, 2009
Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemiasMaria Domenica Cappellini, John Porter, Amal El-Beshlawy, et al.
Journal of Translational Medicine|May 3, 2015
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanomaCarmela Rozera, Giancarlo Antonini Cappellini, Giuseppina D'Agostino, et al.
Melanoma Research|January 3, 2020
Dabrafenib plus trametinib is effective in the treatment of BRAF V600-mutated metastatic melanoma patients: analysis of patients from the dabrafenib plus trametinib Named Patient Program (DESCRIBE II)Victoria Atkinson, Shahneen Sandhu, Geke Hospers, et al.
Annual Review of Biochemistry|May 1, 2018
Ancient Biomolecules and Evolutionary InferenceEnrico Cappellini, Ana Prohaska, Fernando Racimo, et al.
Clinical Therapeutics|August 19, 2007
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with beta-thalassemiaMaria Domenica Cappellini, Mohamed Bejaoui, Leyla Agaoglu, et al.
Haematologica|May 23, 2020
2'-O-methoxyethyl splice-switching oligos correct splicing from IVS2-745 β-thalassemia patient cells restoring HbA production and chain rebalanceAlisa Dong, Valentina Ghiaccio, Irene Motta, et al.
European Journal of Haematology|April 24, 2023
Health-related quality of life in patients with β-thalassemia: Data from the phase 3 BELIEVE trial of luspaterceptMaria Domenica Cappellini, Ali T Taher, Antonio Piga, et al.
European Journal of Gastroenterology & Hepatology|June 5, 2025
A multicenter study on bowel preparation in inflammatory bowel disease patients: comparison between 1L-PEG-ASC and 2L-PEG regimens in an outpatient settingDavide Scalvini, Cristina Bezzio, Stiliano Maimaris, et al.
Cancer Investigation|February 4, 2014
Sequential treatment with ipilimumab and BRAF inhibitors in patients with metastatic melanoma: data from the Italian cohort of the ipilimumab expanded access programPaolo Antonio Ascierto, Ester Simeone, Vanna Chiarion Sileni, et al.
Orphanet Journal of Rare Diseases|June 1, 2019
Current challenges in the management of patients with sickle cell disease - A report of the Italian experienceGiovanna Russo, Lucia De Franceschi, Raffaella Colombatti, et al.
Pageof 87